Comvita (CVNZF) AI Stock Analysis

Top Page

Comvita

(Other OTC:CVNZF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Profitability and cash-flow recoveryThe return to positive earnings and cash generation materially strengthens Comvita’s financial base after prior losses. Revenue growth, improved gross margin and positive free cash flow can support reinvestment, debt reduction and operating resilience if performance is sustained.

Negative Factors

Greater China demand and pricing pressurePersistent demand softness and price competition in Greater China threaten both revenue quality and profitability. Commoditization and parallel imports can weaken brand pricing power, making recovery in this important market dependent on improved demand and stronger channel control.

Comvita (CVNZF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $30.05M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): 7.6
Beta (1Y): -0.11
Revenue Growth: 9.49%
EPS Growth: ―
Country: US
Employees: 395
Sector: Consumer Defensive
Sector Strength: 62
Industry: Packaged Foods

Comvita Business Overview & Revenue Model

Company Description

Comvita Limited, along with its associated entities, specializes in the global production and distribution of natural health products. The company boasts a significant international presence, operating across diverse markets in Australasia, Asia (inc...

Comvita Earnings Call Summary

Earnings Call Date:Aug 26, 2026(Q4-2026)|% Change Since:-9.55%|Next Earnings Date:Oct 10, 2021

Earnings Call SentimentPositive

The call emphasizes a clear recovery: the company returned to profitability, materially improved cash generation, substantially reduced net debt to a net cash position, normalized inventory and secured refinancing and a strategic investor. Commercially, North America and parts of Southeast Asia delivered strong growth, gross margins improved and operating costs were reduced. However, significant challenges remain — notably margin compression in North America, softer demand and pricing pressure in Greater China, outstanding overhead optimization, and near-term risks from harvest variability and geopolitical/market uncertainty. Overall, the positive financial repair and diversification progress materially outweigh the remaining challenges.

Positive Updates

Return to Profitability

Reported NPAT of $7.7 million for FY '26, with normalized EBIT of $16.4 million (above guidance of $15.5 million). Operating profit (reported) was $14.0 million, demonstrating recovery to a profitable position.

Negative Updates

China Market Softness and Pricing Pressure

Greater China remains the toughest market with softer consumer demand, continued commoditization and pricing pressure from parallel imports and lower-price competitors; contribution margins in Greater China declined to approximately 14%.

Company Guidance

Management gave no numeric FY‑27 guidance at the call — saying it is too early and that guidance will be provided once apiary crop and channel visibility improves (notably after November) — but framed a disciplined outlook underpinned by FY‑26 metrics: revenue of $213.0m, reported NPAT $7.7m, normalized EBIT $16.4m (vs prior guidance $15.5m) and operating profit $14.0m; operating cash flow of $40.3m and positive free cash flow; net debt turned from $62.4m to net cash $0.5m; inventory reduced from $89.0m to $79.9m (≈$80m target); gross margin recovered to 53.9% (vs a normalized FY‑25 50.8%); operating expenses were cut by $8m; North America sales rose to $58.7m (from $28.7m) though contribution margin fell 14.1%→6.6%, Greater China contribution margin is ~14%; capital raise issue costs were $3.42m with failed SIA costs ~$1.4m, refinancing provides covenant headroom to Sept 2028, and dividends will only resume when earnings, cash generation and balance sheet metrics sustainably support them.

Comvita Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

CVNZF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NZ:ATM	69Neutral	NZD 6.29B	27.87	17.63%	7.29%	3.84%	6.53%
NZ:SAN	66Neutral	NZD 640.52M	8.90	9.48%	1.72%	-4.16%	91.88%
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
NZ:NZK	54Neutral	NZD 129.16M	-13.64	-4.98%	―	―	―
NZ:SML	49Neutral	NZD 310.65M	-4.24	-10.58%	―	-7.94%	-95.77%
NZ:MEE	40Underperform	NZD 7.39M	-2.30	―	―	-12.36%	79.80%

* Consumer Defensive Sector Average

Performance Comparison

CVNZF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CVNZF	Comvita	0.43	0.01	1.67%
NZ:ATM	a2 Milk Company Ltd.	8.64	-1.57	-15.39%
NZ:NZK	New Zealand King Salmon Investments Ltd.	0.24	0.04	20.00%
NZ:SAN	Sanford	6.85	0.80	13.15%
NZ:SML	Synlait Milk Ltd.	0.52	-0.20	-28.47%
NZ:MEE	Me Today Limited	0.07	0.00	0.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Comvita AI Stock Analysis